Paclitaxel NDC 25021-255

Product information

Brand name (proprietary)

Paclitaxel

Generic name (nonproprietary)

paclitaxel

Active ingredients

Paclitaxel — 6 mg/mL

Dosage form

Injection, Solution

Route

Intravenous

Labeler

Sagent Pharmaceuticals

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 207326

Marketing start

Feb 1, 2024

Listing expires

Dec 31, 2026

Other FDA classes

Microtubule Inhibition (Physiologic effect)

Identifiers

Product ID 25021-255_5f3284c1-d03f-4fca-bb78-1ead3280af60SPL ID 5f3284c1-d03f-4fca-bb78-1ead3280af60SPL set ID 5721b9bf-c3c1-4b73-b96c-5fbe3147b6a5RxCUI 312199UNII P88XT4IS4D

Pharmacologic class

Microtubule Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021025505 followed by a unit qualifier and the quantity Copy

Package 25021-0255-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 207326

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.